National Journal of Pharmaceutical Sciences
  • Printed Journal
  • Refereed Journal
  • Peer Reviewed Journal

P-ISSN: 2788-9262, E-ISSN: 2788-9270

National Journal of Pharmaceutical Sciences


2021, Vol. 1, Issue 2, Part A
A review of the combination of xanthine and bronchodilator drug in mouth-dissolving film for asthma treatment


Author(s): Devendra Singh Lodhi, Aakash Singh Panwar, Pradeep Golani and Megha Verma

Abstract: There has been an increase in demand for caregiver dosage forms over the last two decades. In the oral cavity, mouth dissolving film (MDF) dissolves swiftly. Oral films that dissolve in your mouth function best when combined with medications that act quickly, such as Xanthine category drugs (Salbutamol Sulphate) and Xanthene Derivative Theophylline. According to the World Health Organization (WHO), asthma affects one in six adults and a quarter of all children, according to the World Health Organization (WHO). A child's admission to the hospital is often due to asthma, which is one of the most prevalent reasons for admission. During an asthma attack, quick-relief or rescue drugs are used to relax and open the airways, as well as ease symptoms. If prescribed, these medications can also be administered prior to exercise. To treat asthma, a combination of Salbutamol Sulfate and Theophylline is available in tablet form under the brand name "Theo-Asthalin." Oral films seem to be the most efficacious formulation. As a consequence, children with asthma should receive support from drugs given in the form of mouth-dissolving films, since they provide better patient compliance and an appropriate treatment method.

Pages: 49-56 | Views: 231 | Downloads: 83

Download Full Article: Click Here
How to cite this article:
Devendra Singh Lodhi, Aakash Singh Panwar, Pradeep Golani, Megha Verma. A review of the combination of xanthine and bronchodilator drug in mouth-dissolving film for asthma treatment. Nat J Pharm Sci 2021;1(2):49-56.


National Journal of Pharmaceutical Sciences